Literature DB >> 575476

Effect of human plasma apolipoproteins on the activity of purified lecithin: cholesterol acyltransferase.

J J Albers, J Lin, G P Roberts.   

Abstract

An active preparation of lecithin: cholesterol acyltransferase (LCAT, EC 2.3.1.43) was isolated from human plasma by density ultracentrifugation, high-density lipoprotein affinity chromatography, DEAE-Sepharose and hydroxylapatite chromatography. This enzyme preparation gave a single band on polyacrylamide gel electrophoresis in 8 M urea and on sodium dodecyl sulfate gel electrophoresis. Upon analytical isoelectric focusing the enzyme separated into at least five isoforms with isoelectric points ranging from 5.1 to 5.5. The enzyme with an apparent molecular weight of 66,000 +/- 2,000 was characterized by a high content of glutamic acid, aspartic acid, leucine and glycine and contained approximately 31 moles of glucosamine/10(3) moles of protein and no galactosamine. The purified enzyme, stored at 20-40 microgram/ml at 4 degrees C, had a half-life of 26 +/- 4 days. The effect of purified human plasma apolipoproteins A-I, A-II, C-I, C-II, C-III and D on the activity of purified LCAT was studied, using egg-yolk lecithin (40 microM): cholesterol (10 microM) vesicles prepared in 1.25% ethanol in the absence or presence of 0.5% albumin. Addition of albumin to the incubation mixture nearly doubled the esterification rate of LCAT with A-I as activator (n=4), whereas it inhibited esterification by approximately 35% (n=3) if C-I was the activator. Maximum activation by C-I yielded only 13 +/- 6% (vesicles with albumin) or 42 +/- 5% (vesicles without albumin) of the LCAT activity obtained with A-I. Each of the apoproteins A-II, C-II, C-III and D inhibited the LCAT reaction in the presence of A-I or C-I at concentrations needed for maximal activation. Contrary to previous work, apolipoprotein D does not appear to be an activator of LCAT. LCAT activity is significantly affected by albumin and the apolipoproteins A-II, C-II, C-III, and D.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 575476

Source DB:  PubMed          Journal:  Artery        ISSN: 0098-6127


  13 in total

1.  Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein Cl.

Authors:  N S Shachter; T Ebara; R Ramakrishnan; G Steiner; J L Breslow; H N Ginsberg; J D Smith
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Serum markers may distinguish biliary atresia from other forms of neonatal cholestasis.

Authors:  Hongtao Wang; James P Malone; Petra Erdmann Gilmore; Alan E Davis; John C Magee; R Reid Townsend; Robert O Heuckeroth
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-04       Impact factor: 2.839

3.  [Apolipoproteinopathies].

Authors:  G Assmann
Journal:  Klin Wochenschr       Date:  1983-02-15

4.  Isolation and characterisation of a cDNA clone for human apolipoprotein CI and assignment of the gene to chromosome 19.

Authors:  F Tata; I Henry; A F Markham; S C Wallis; D Weil; K H Grzeschik; C Junien; R Williamson; S E Humphries
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

5.  Localization of cholesteryl sulfate in human spermatozoa in support of a hypothesis for the mechanism of capacitation.

Authors:  J Langlais; M Zollinger; L Plante; A Chapdelaine; G Bleau; K D Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

6.  Characterisation of mRNAs encoding the precursor for human apolipoprotein CI.

Authors:  T J Knott; M E Robertson; L M Priestley; M Urdea; S Wallis; J Scott
Journal:  Nucleic Acids Res       Date:  1984-05-11       Impact factor: 16.971

7.  Comparative specificity of plasma lecithin:cholesterol acyltransferase from ten animal species.

Authors:  D Grove; H J Pownall
Journal:  Lipids       Date:  1991-06       Impact factor: 1.880

8.  Changes in helical content or net charge of apolipoprotein C-I alter its affinity for lipid/water interfaces.

Authors:  Nathan L Meyers; Libo Wang; Olga Gursky; Donald M Small
Journal:  J Lipid Res       Date:  2013-05-13       Impact factor: 5.922

9.  Activation of lecithin:cholesterol acyltransferase by a synthetic model lipid-associating peptide.

Authors:  H J Pownall; A Hu; A M Gotto; J J Albers; J T Sparrow
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

Review 10.  Apolipoprotein D in lipid metabolism and its functional implication in atherosclerosis and aging.

Authors:  German Perdomo; H Henry Dong
Journal:  Aging (Albany NY)       Date:  2009-01       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.